ACUTUS MEDICAL, INC.

(AFIB)
  Report
Delayed Nasdaq  -  04:00 2022-08-12 pm EDT
1.660 USD    0.00%
08/11ACUTUS MEDICAL : Unaudited Pro Forma Condensed Consolidated Financial Information - Form 8-K/A
PU
08/11ACUTUS MEDICAL, INC. Other Events (form 8-K/A)
AQ
08/11ACUTUS MEDICAL, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Acutus Medical Stock Jumps 30% on FDA Clearance for Heart Product

06/27/2022 | 04:33am EDT

By Will Feuer


Shares of arrhythmia management company Acutus Medical Inc. jumped some 20% in premarket trading Monday after the company said the Food and Drug Administration has cleared the commercial launch of an expanded suite of left-heart access products.

The company's suite of products will now include its AcQCross Qx system for use with the TruSeal and FXD delivery system for the Watchman LAAC Device.

Acutus Medical said gaining access to the left atrium of the heart typically requires physicians to cross the septum, a complicated process that often involves the exchange of wires and needles while trying to achieve the proper angle and location on the septum.

The launch of AcQCross and its compatibility with the Watchman device will help doctors reposition during left-heart access procedures without withdrawing or exchanging needles or wires, the company said. It said left-atrial appendage closure procedures are expected to total more than 50,000 in 2022.

"The expanded AcQCross product line allows us to bring this innovative technology to a wider range of procedure categories that should drive sustained growth in this portfolio," interim Chief Executive David Roman said.

Shares rose 30% to 70 cents a share in premarket trading. The stock closed on Friday about 84% lower this year.


Write to Will Feuer at Will.Feuer@wsj.com


(END) Dow Jones Newswires

06-27-22 0633ET

All news about ACUTUS MEDICAL, INC.
08/11ACUTUS MEDICAL : Unaudited Pro Forma Condensed Consolidated Financial Information - Form 8..
PU
08/11ACUTUS MEDICAL, INC. Other Events (form 8-K/A)
AQ
08/11ACUTUS MEDICAL, INC. Management's Discussion and Analysis of Financial Condition and R..
AQ
08/11ACUTUS MEDICAL : Reports Second Quarter 2022 Financial Results - Form 8-K
PU
08/11TRANSCRIPT : Acutus Medical, Inc., Q2 2022 Earnings Call, Aug 11, 2022
CI
08/11Earnings Flash (AFIB) ACUTUS MEDICAL Reports Q2 Revenue $4.1M, vs. Street Est of $3.97M
MT
08/11Acutus Medical Reports Second Quarter 2022 Financial Results
AQ
08/11Acutus Medical, Inc. Reports Earnings Results for the Second Quarter and Six Months End..
CI
08/02Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
AQ
07/29ACUTUS MEDICAL, INC. : Change in Directors or Principal Officers, Financial Statements and..
AQ
More news
Analyst Recommendations on ACUTUS MEDICAL, INC.
More recommendations
Financials (USD)
Sales 2022 16,3 M - -
Net income 2022 -78,8 M - -
Net cash 2022 19,2 M - -
P/E ratio 2022 -0,61x
Yield 2022 -
Capitalization 47,1 M 47,1 M -
EV / Sales 2022 1,71x
EV / Sales 2023 1,10x
Nbr of Employees 338
Free-Float 91,7%
Chart ACUTUS MEDICAL, INC.
Duration : Period :
Acutus Medical, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ACUTUS MEDICAL, INC.
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 6
Last Close Price 1,66 $
Average target price 3,38 $
Spread / Average Target 103%
EPS Revisions
Managers and Directors
David Harrison Roman President, CEO, CFO & Director
R. Scott Huennekens Executive Chairman
Derrick Chou Chief Technology Officer
Rick Kimes Senior Vice President-Operations
David P. Bonita Independent Director
Sector and Competitors
1st jan.Capi. (M$)
ACUTUS MEDICAL, INC.-51.32%47
THERMO FISHER SCIENTIFIC-9.60%232 151
DANAHER CORPORATION-9.50%211 818
INTUITIVE SURGICAL, INC.-33.66%84 285
EDWARDS LIFESCIENCES CORPORATION-19.10%64 424
SIEMENS HEALTHINEERS AG-21.51%60 400